| 1 |
33629198 | Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors. | 2021 Aug |
1 |
| 2 |
33676682 | Detection of colorectal cancer using a small molecular fluorescent probe targeted against c-Met. | 2021 May 1 |
3 |
| 3 |
32827692 | HGF protected against diabetic nephropathy via autophagy-lysosome pathway in podocyte by modulating PI3K/Akt-GSK3β-TFEB axis. | 2020 Nov |
1 |
| 4 |
29440379 | Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models. | 2018 Feb 27 |
4 |
| 5 |
27057482 | cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer. | 2016 |
2 |
| 6 |
26531163 | Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. | 2015 Dec 24 |
1 |
| 7 |
24170771 | Off-target effects of c-MET inhibitors on thyroid cancer cells. | 2014 Jan |
2 |
| 8 |
25193856 | Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer. | 2014 Oct 15 |
1 |
| 9 |
25277255 | Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer. | 2014 Oct 2 |
1 |
| 10 |
24140933 | Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model. | 2013 Dec |
2 |
| 11 |
24220141 | Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis. | 2013 Dec |
1 |
| 12 |
22233293 | Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein. | 2012 Jul |
2 |
| 13 |
22269210 | HGF/c-Met pathway is one of the mediators of sunitinib-induced tumor cell type-dependent metastasis. | 2012 Jul 1 |
2 |
| 14 |
22585997 | Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. | 2012 Mar |
1 |